• Therapeutic Cataract & Refractive
  • Lens Technology
  • Glasses
  • Ptosis
  • Comprehensive Eye Exams
  • AMD
  • COVID-19
  • DME
  • Ocular Surface Disease
  • Optic Relief
  • Geographic Atrophy
  • Cornea
  • Conjunctivitis
  • LASIK
  • Myopia
  • Presbyopia
  • Allergy
  • Nutrition
  • Pediatrics
  • Retina
  • Cataract
  • Contact Lenses
  • Lid and Lash
  • Dry Eye
  • Glaucoma
  • Refractive Surgery
  • Comanagement
  • Blepharitis
  • OCT
  • Patient Care
  • Diabetic Eye Disease
  • Technology

Preoperative visual decrease possible after phacoemulsification surgery

Article

Though rare, visual decreases can occur within 1 day postoperatively after phacoemulsification surgery.

Visual decreases are rare after phacoemulsification, but they can occur within 1 day postoperatively,1 according to professors Harry Rosen and Stephen Vernon from, respectively, the Charing Cross Hospital, Imperial College Healthcare National Health Service Trust, London, and the Ophthalmic Service, The Park Hospital, Nottingham, UK.

The safety and efficacy of phacoemulsification have increased to the point that it is no longer standard practice to examine patients the day after surgery, they pointed out. However, because of the rarity of visual decreases, the investigators stated, “Clinicians are therefore likely to be unfamiliar with the potential causes of reduced vision when presented with a patient in the immediate postoperative period.”

In light of this, Rosen and Vernon conducted a literature review to pinpoint the cause of visual decreases early postoperatively. They found various optical, anterior segment, lens-related and posterior segment causes, such as a shallow anterior chamber, lens dislocation, refractive surprise of 1 diopter or more, corneal abrasion, corneal edema, corneal endothelial decompensation, toxic anterior segment syndrome, hyphema, endophthalmitis, opacification, vitreous hemorrhage, and macular holes, among other.

However, paracentral acute middle maculopathy (PAMM), according to the authors, is unique in that it lacks positive findings during clinical examinations, and should be considered as a diagnosis of exclusion.

The investigators described that postoperatively, PAMM is characterized by a dense central scotoma presenting on the first postoperative day, often with no clinical signs on the examination.

“The diagnosis is defined by a hyperreflective band on optical coherence tomography confined to the retinal inner nuclear layer (INL), with subsequent thinning and loss of the negative signal layer of the INL,” they said.

PAMM is believed to result from transient ischemia of the deep and intermediate retinal capillary plexus, causing irreversible INL necrosis.

“Clinicians are becoming increasingly unfamiliar with the causes of visual loss 1 day following cataract surgery," Rosen and Vernon concluded. "We reviewed the differential causes and their presentations as an aid to clinicians reviewing such patients in emergency care. PAMM is a unique condition in its paucity of positive clinical examination findings, and should be considered as a diagnosis of exclusion, with the appropriate radiological evidence.”

Reference
1. Rosen H, Vernon S. Unexpected poor vision within 24 h of uneventful phacoemulsification surgery—a review. J Clin Med. 2023;12: 48; https://doi.org/10.3390/jcm12010048

Related Videos
Deborah Ferrington details a session on mitochondrial maintenance and retinal health in patients with AMD at ARVO 2024
Dr. John Sheppard discusses results from trials testing the efficacy of eye drops to treat dry eye disease
Kelsey Roelofs, MD, details the best methods to identify thyroid eye disease at CIME 2024
David A. Berntsen, OD, PhD, FAAO, outlines his presentation on the BLINK 2 study presented at the 2024 ARVO meeting
Marc Bloomenstein, OD's Insights from CIME on Diagnosing and Treating Demodex Blepharitis
James Katz, MD, talks Demodex blepharitis treatment options in CIME presentation
Neda Shamie, MD, details the upcoming CIME 2024 meeting
© 2024 MJH Life Sciences

All rights reserved.